1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Small Intestine Cancer Global Clinical Trials Review, H1, 2014

Small Intestine Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Small Intestine Cancer Global Clinical Trials Review, H1, 2014" provides data on the Small Intestine Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small Intestine Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Small Intestine Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Small Intestine Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents2
List of Tables 4
List of Figures 5
Introduction 6
Small Intestine Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by G7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Small Intestine Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Clinical Trials by End Point Status 21
Unaccomplished Trials of Small Intestine Cancer 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Small Intestine Cancer Therapeutics Clinical Trials 26
Prominent Drugs 28
Clinical Trial Profiles 29
Clinical Trial Overview of Top Companies 29
Vion Pharmaceuticals, Inc. (Inactive) 29
Clinical Trial Overview of Vion Pharmaceuticals, Inc. (Inactive) 29
Silence Therapeutics AG 30
Clinical Trial Overview of Silence Therapeutics AG 30
Otsuka Pharmaceutical Co., Ltd. 31
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 31
Oncothyreon Inc. 32
Clinical Trial Overview of Oncothyreon Inc. 32
Novogen Limited 33
Clinical Trial Overview of Novogen Limited 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Eisai Inc. 36
Clinical Trial Overview of Eisai Inc. 36
Burzynski Research Institute, Inc. 37
Clinical Trial Overview of Burzynski Research Institute, Inc. 37
Clinical Trial Overview of Top Institutes / Government 38
National Cancer Institute 38
Clinical Trial Overview of National Cancer Institute 38
Memorial Sloan Kettering Cancer Center 40
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 40
National Institutes of Health Clinical Center 41
Clinical Trial Overview of National Institutes of Health Clinical Center 41
North Central Cancer Treatment Group 42
Clinical Trial Overview of North Central Cancer Treatment Group 42
Mayo Clinic 43
Clinical Trial Overview of Mayo Clinic 43
Ohio State University Comprehensive Cancer Center 44
Clinical Trial Overview of Ohio State University Comprehensive Cancer Center 44
Robert H. Lurie Comprehensive Cancer Center of Northwestern University 45
Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 45
University of Wisconsin Madison 46
Clinical Trial Overview of University of Wisconsin Madison 46
Fox Chase Cancer Center 47
Clinical Trial Overview of Fox Chase Cancer Center 47
New York University School of Medicine 48
Clinical Trial Overview of New York University School of Medicine 48
Five Key Clinical Profiles 49
Appendix 113
Abbreviations 113
Definitions 113
Research Methodology 114
Secondary Research 114
About GlobalData 115
Contact Us 115
Disclaimer 115
Source 116

List of Tables
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Small Intestine Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 18
Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 19
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Small Intestine Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014* 22
Small Intestine Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 22
Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 24
Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vion Pharmaceuticals, Inc. (Inactive), 2014* 29
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Silence Therapeutics AG, 2014* 30
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2014* 31
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oncothyreon Inc., 2014* 32
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novogen Limited, 2014* 33
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014* 35
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2014* 36
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Burzynski Research Institute, Inc., 2014* 37
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 38
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014* 40
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2014* 41
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2014* 42
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2014* 43
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Ohio State University Comprehensive Cancer Center, 2014* 44
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2014* 45
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Wisconsin Madison, 2014* 46
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Fox Chase Cancer Center, 2014* 47
Small Intestine Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 48

List of Figures
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Small Intestine Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Small Intestine Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Small Intestine Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Small Intestine Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Small Intestine Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Small Intestine Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Small Intestine Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 18
Small Intestine Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 19
Small Intestine Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 20
Small Intestine Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014* 21
Small Intestine Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 23
Small Intestine Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 24
Small Intestine Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 25
Small Intestine Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 26
Small Intestine Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 28
GlobalData Methodology 114

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Lung Cancer: Analytical Tool

Lung Cancer: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Brain Cancer: Analytical Tool

August 2016 $ 8096

Breast Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.